The two chains said they would begin the certification process under a new F.D.A. regulation that will allow retail pharmacies to dispense the prescription pills for the first time.
Category: Food and Drug Administration
-
Abortion Pills Can Now Be Offered at Retail Pharmacies, F.D.A. Says
Mifepristone, the first of two drugs in medication abortions, previously had to be dispensed only by clinics, doctors or a few mail-order pharmacies. Now, if local drugstores or chains like CVS agree to certain rules, they can provide it.
-
Legal Use of Hallucinogenic Mushrooms Begins in Oregon
On Jan. 1, Oregon became the first state to allow adult use of psilocybin “magic” mushrooms. Licensed guides will likely determine whether the program is a success.
-
Congressional Investigation into Alzheimer’s Drug Aduhelm Faults the F.D.A. and Biogen
The report said the F.D.A.’s approval process for Aduhelm was “rife with irregularities” and criticized Biogen for setting an “unjustifiably high price.”
-
Will This Device Protect Athletes’ Brains, or Only Make Them Think It Does?
More and more pro and college athletes are trying on the Q-Collar as they search for something, anything, that might keep their brains safe. But does it work?
-
Can a Federally Funded ‘Netflix Model’ Fix the Broken Market for Antibiotics?
Shortages and drug-resistant germs have renewed attention on a $6 billion proposal in Congress that would reconfigure the way antimicrobial drugs are developed and sold.
-
Brain Implants Have Begun to Restore Functions, but Advances Are Slow
But achieving full-body restoration of movement, as Elon Musk envisions with such devices, is considered far into the future, if at all.
-
Supreme Court Refuses to Block California’s Ban on Flavored Tobacco
The state’s voters had overwhelmingly supported letting a two-year-old law take effect, and lower courts had refused to put it on hold.
-
Vaping Settlement by Juul Is Said to Total $1.7 Billion
The proposed deal would resolve thousands of lawsuits in multidistrict litigation based in Northern California.
-
Lasik Patients Should Be Warned of Complications, FDA Draft Says
Draft recommendations by the agency describe dry eyes, visual disturbances and other side effects of the procedure. Surgeons say the benefits are being ignored.